These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7390696)

  • 1. Effects of nafenopin, diphenylhydantoin, phenobarbitone and some acetylenes on body composition: is there a relationship between decreased carcass lipid and increased liver size and induction of drug metabolizing enzymes?
    Arch JR; Green A; Cawthorne MA
    Int J Obes; 1980; 4(1):1-10. PubMed ID: 7390696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver.
    Stäubli W; Bentley P; Bieri F; Fröhlich E; Waechter F
    Carcinogenesis; 1984 Jan; 5(1):41-6. PubMed ID: 6140087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acetylenedicarboxylate: relationship between decreased carcass lipid and increased liver size and lean body weight.
    Arch JR; Cornish S; Green A; Cawthorne MA
    Int J Obes; 1979; 3(4):289-99. PubMed ID: 393646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
    Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug metabolism and morphologic changes in the liver of nafenopin-treated rats.
    Tuchweber B; Kourounakis P; Latour JG
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):309-21. PubMed ID: 984981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nafenopin (SU-13,437) on liver functions. Hepatic uptake and biliary excretion of ouabain in the rat.
    Meijer DK; Bognacki J; Levine WG
    Drug Metab Dispos; 1975; 3(3):220-5. PubMed ID: 238821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some biochemical changes associated with nafenopin-induced liver growth in the rat.
    Levine WG; Ord MG; Stocken LA
    Biochem Pharmacol; 1977 May; 26(10):939-42. PubMed ID: 861041
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of various drugs on lipid content and drug metabolizing enzymes in rat liver following experimentally induced fatty degeneration].
    Elies W; Heni N; Remmer H
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):317-8. PubMed ID: 4253759
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nafenopin on the uptake of bilirubin and sulfobromophthalein by isolated perfused rat liver.
    Gärtner U; Stockert RJ; Levine WG; Wolkoff AW
    Gastroenterology; 1982 Dec; 83(6):1163-9. PubMed ID: 6751925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic drug metabolism and the activities of NADPH generating enzymes and glucose-6-phosphatase in phenobarbital treated genetically obese (ob/ob) mice.
    Stengard JH; Saarni HU; Karvonen RI; Lahtela JT; Kärki NT; Stenbäck F; Sotaniemi EA
    Biomed Pharmacother; 1987; 41(7):389-96. PubMed ID: 2833324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcass and liver composition following acute oxytetracycline treatment of ob/ob mice.
    Dubuc PU; Keith LD; Oey H; Mobley PW
    J Nutr; 1978 May; 108(5):874-80. PubMed ID: 641602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on cerium-induced liver injury in rats after pretreatment with spironolactone, phenobarbital, pregnenolone-16 alpha-carbonitrile and nafenopin.
    Bjondahl K
    Arzneimittelforschung; 1978; 28(5):817-9. PubMed ID: 581962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No increase of apoptosis in regressing mouse liver after withdrawal of growth stimuli or food restriction.
    Bursch W; Wastl U; Hufnagl K; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):507-14. PubMed ID: 15728705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.
    Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA
    Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
    Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
    Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
    Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytosolic and microsomal epoxide hydrolases by the hypolipidaemic compound nafenopin in the mouse liver.
    Waechter F; Bieri F; Stäubli W; Bentley P
    Biochem Pharmacol; 1984 Jan; 33(1):31-4. PubMed ID: 6704141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.